619492.html
Crispr Therapeutics' general counsel sells shares worth $619,492
Wed, 19 Feb 2025 14:38:00 GMT
According to a Form 4 filing with the Securities and Exchange Commission, Kasinger sold a total of 11,542 shares over two days, resulting in a total transaction value of $619,492. The shares were ...